Wang Q M, Park I K, Fiol C J, Roach P J, DePaoli-Roach A A
Department of Biochemistry and Molecular Biology, Indiana University School of Medicine, Indianapolis 46202-5122.
Biochemistry. 1994 Jan 11;33(1):143-7. doi: 10.1021/bi00167a018.
Phosphorylation of inhibitor 2, the regulatory subunit of the ATP-Mg-dependent protein phosphatase, by glycogen synthase kinase 3 (GSK-3) causes activation of the phosphatase. Prior phosphorylation by casein kinase II has been shown to enhance both phosphorylation and activation of the phosphatase by GSK-3 (DePaoli-Roach, A. A. (1984) J. Biol. Chem. 259, 12144-12152). Reported here is a comparison of the phosphorylation of inhibitor 2 by two defined isoforms of GSK-3, GSK-3 alpha and GSK-3 beta. GSK-3 beta was a significantly better inhibitor 2 kinase than was GSK-3 alpha. The Vmax/Km value for GSK-3 beta was approximately 10-fold higher than that for GSK-3 alpha. GSK-3 beta phosphorylated inhibitor 2 to a stoichiometry of approximately 1.0 mol of phosphate/mol of inhibitor 2. The phosphorylation by GSK-3 beta was determined to be exclusively at Thr-72 on the basis of the inability of the enzyme to modify a mutant inhibitor 2 in which Thr-72 was changed to alanine. Prior phosphorylation by casein kinase II promoted the action of GSK-3 alpha in keeping with earlier reports using undefined GSK-3 preparations. Phosphorylation by GSK-3 beta, in contrast, was unaffected by the previous action of casein kinase II. These results suggest that there can be important differences in substrate recognition by different isoforms of the same protein kinase and may help explain why some reported GSK-3 substrates require prior phosphorylation whereas other do not.(ABSTRACT TRUNCATED AT 250 WORDS)
糖原合酶激酶3(GSK-3)使ATP-镁依赖性蛋白磷酸酶的调节亚基抑制剂2磷酸化,从而激活该磷酸酶。酪蛋白激酶II先前的磷酸化作用已被证明可增强GSK-3对该磷酸酶的磷酸化及激活作用(德保利-罗奇,A.A.(1984年)《生物化学杂志》259卷,12144 - 12152页)。本文报道了GSK-3的两种特定亚型GSK-3α和GSK-3β对抑制剂2磷酸化作用的比较。GSK-3β作为抑制剂2激酶比GSK-3α明显更有效。GSK-3β的Vmax/Km值比GSK-3α高约10倍。GSK-3β将抑制剂2磷酸化,化学计量比约为每摩尔抑制剂2含1.0摩尔磷酸盐。基于该酶无法修饰苏氨酸72被替换为丙氨酸的突变型抑制剂2,确定GSK-3β的磷酸化作用仅发生在苏氨酸72处。与早期使用未明确的GSK-3制剂的报道一致,酪蛋白激酶II先前的磷酸化促进了GSK-3α的作用。相比之下,GSK-3β的磷酸化不受酪蛋白激酶II先前作用的影响。这些结果表明,同一蛋白激酶的不同亚型在底物识别上可能存在重要差异,这或许有助于解释为何一些报道的GSK-3底物需要先前的磷酸化,而另一些则不需要。(摘要截选至250词)